| Product Type | Impurity Standards |
| CAT. No. | MRL-D59002 |
| CAS. No. | NA |
| Mol. Formula | C82H102ClN19O17 |
| Mol. Weight | 1661.3 |
| Chemical Name | (4S)-N-(4-((2S,5S,8R,11R,14R)-2-(((2R)-1-(((2S)-1-(((2R)-1-((R)-2-(((R)-1-amino-1-oxopropan-2-yl)carbamoyl)pyrrolidin-1-yl)-6-((1-nitrosoethyl)amino)-1-oxohexan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-1-oxo-3-(4-ureidophenyl)propan-2-yl)carbamoyl)-11 |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Custom Synthesis |
Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Degarelix. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds. Degarelix is a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of advanced prostate cancer. Its chemical structure inhibits the secretion of gonadotropins, leading to a reduction in testosterone levels. By suppressing testosterone, degarelix helps slow the growth of prostate cancer cells. Unlike GnRH agonists, degarelix rapidly and consistently lowers testosterone levels without the initial surge, preventing potential exacerbation of symptoms. This makes it a valuable option in managing prostate cancer, particularly in situations where swift testosterone suppression is crucial for therapeutic efficacy. Buy high quality N-Nitroso Degarelix from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of N-Nitroso Degarelix.